A detailed history of Castle Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Castle Wealth Management LLC holds 1,718 shares of ABBV stock, worth $292,575. This represents 0.18% of its overall portfolio holdings.

Number of Shares
1,718
Previous 1,190 44.37%
Holding current value
$292,575
Previous $204,000 66.18%
% of portfolio
0.18%
Previous 0.12%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$163.84 - $199.33 $86,507 - $105,246
528 Added 44.37%
1,718 $339,000
Q2 2024

Jul 22, 2024

BUY
$154.79 - $180.76 $184,200 - $215,104
1,190 New
1,190 $204,000
Q1 2023

May 04, 2023

SELL
$144.61 - $166.54 $3,615 - $4,163
-25 Reduced 1.93%
1,273 $202,000
Q4 2022

Feb 09, 2023

SELL
$138.31 - $165.87 $14,384 - $17,250
-104 Reduced 7.42%
1,298 $209,000
Q2 2022

Aug 01, 2022

BUY
$137.62 - $174.96 $192,943 - $245,293
1,402 New
1,402 $215,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Castle Wealth Management LLC Portfolio

Follow Castle Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Wealth Management LLC with notifications on news.